HCPCS Level II › J

HCPCS Level II codes starting with J

1,255 codes, page 13 of 13. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
J9313 Injection, moxetumomab pasudotox-tdfk, 0.01 mg Valid
J9314 Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg Valid
J9315 Injection, romidepsin, 1 mg through FY2026 Terminated
J9316 Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg Valid
J9317 Injection, sacituzumab govitecan-hziy, 2.5 mg Valid
J9318 Injection, romidepsin, non-lyophilized, 0.1 mg Valid
J9319 Injection, romidepsin, lyophilized, 0.1 mg Valid
J9320 Injection, streptozocin, 1 gram Valid
J9321 Injection, epcoritamab-bysp, 0.16 mg Valid
J9322 Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg Valid
J9323 Injection, pemetrexed ditromethamine, 10 mg Valid
J9324 Injection, pemetrexed (pemrydi rtu), 10 mg Valid
J9325 Injection, talimogene laherparepvec, per 1 million plaque forming units Valid
J9326 Injection, telisotuzumab vedotin-tllv, 1 mg Valid
J9328 Injection, temozolomide, 1 mg Valid
J9329 Injection, tislelizumab-jsgr, 1mg Valid
J9330 Injection, temsirolimus, 1 mg Valid
J9331 Injection, sirolimus protein-bound particles, 1 mg Valid
J9332 Injection, efgartigimod alfa-fcab, 2mg Valid
J9333 Injection, rozanolixizumab-noli, 1 mg Valid
J9334 Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc Valid
J9340 Injection, thiotepa, 15 mg through FY2026 Terminated
J9341 Injection, thiotepa (tepylute), 1 mg Valid
J9342 Injection, thiotepa, not otherwise specified, 1 mg Valid
J9345 Injection, retifanlimab-dlwr, 1 mg Valid
J9347 Injection, tremelimumab-actl, 1 mg Valid
J9348 Injection, naxitamab-gqgk, 1 mg Valid
J9349 Injection, tafasitamab-cxix, 2 mg Valid
J9350 Injection, mosunetuzumab-axgb, 1 mg Valid
J9351 Injection, topotecan, 0.1 mg Valid
J9352 Injection, trabectedin, 0.1 mg through FY2026 Terminated
J9353 Injection, margetuximab-cmkb, 5 mg Valid
J9354 Injection, ado-trastuzumab emtansine, 1 mg Valid
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg Valid
J9356 Injection, trastuzumab, 10 mg and hyaluronidase-oysk Valid
J9357 Injection, valrubicin, intravesical, 200 mg Valid
J9358 Injection, fam-trastuzumab deruxtecan-nxki, 1 mg Valid
J9359 Injection, loncastuximab tesirine-lpyl, 0.075 mg Valid
J9360 Injection, vinblastine sulfate, 1 mg Valid
J9361 Injection, efbemalenograstim alfa-vuxw, 0.5 mg Valid
J9362 Injection, trabectedin, 0.01 mg Valid
J9370 Vincristine sulfate, 1 mg Valid
J9371 Injection, vincristine sulfate liposome, 1 mg through FY2026 Terminated
J9376 Injection, pozelimab-bbfg, 1 mg Valid
J9380 Injection, teclistamab-cqyv, 0.5 mg Valid
J9381 Injection, teplizumab-mzwv, 5 mcg Valid
J9382 Injection, zenocutuzumab-zbco, 1 mg Valid
J9390 Injection, vinorelbine tartrate, 10 mg Valid
J9393 Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg Valid
J9394 Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg Valid
J9395 Injection, fulvestrant, 25 mg Valid
J9400 Injection, ziv-aflibercept, 1 mg Valid
J9600 Injection, porfimer sodium, 75 mg Valid
J9601 Injection, linvoseltamab-gcpt, 1 mg Valid
J9999 Not otherwise classified, antineoplastic drugs Valid
Page 13 of 13